Abstract
Background: With the postulation that ribavirin, an antiviral agent, can modulate the clinical course of severe acute hepatitis due to hepatitis E virus (HEV), a clinical trial was conducted in patients with acute hepatitis E.
Cite
CITATION STYLE
APA
Rahman, S., Al-Mahtab, M., Ahmed, F., Fazal Karim, M., & Dalil Uddin, M. (2013). Ribavirin as a Therapeutic Modality in Patients with Severe Acute Hepatitis E. Euroasian Journal of Hepato-Gastroenterology, 3(1), 39–41. https://doi.org/10.5005/jp-journals-10018-1060
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free